Close menu




Banks

Photo credits: pixabay.com

Commented by Lars Winter on October 20th, 2026 | 05:44 CEST

Gold, Money and Healthcare: Lahontan Gold, Goldman Sachs and Johnson & Johnson – 3 Promising Stocks Under Review

  • Gold
  • Gold mine
  • Gold price
  • Commodities
  • Precious metal
  • Mining
  • Banks
  • Financial services providers
  • Pharmaceutical industry
  • Medicines
  • Health
  • Medicine

Canadian gold exploration company Lahontan Gold is generating optimism. A preliminary economic assessment of its key mining project in Nevada recently assigned the Santa Fe Mine a calculated project value of USD 820 million. This is a multiple of its current market capitalisation, giving the stock considerable upside potential. Goldman Sachs has also surprised the market in recent days with a strong set of financial results. Pharmaceutical giant Johnson & Johnson, meanwhile, raised its outlook despite one minor setback. Three promising companies with positive news are under review.

Read